Company attributes
Industry
CEO
Pitchbook URL
Legal Name
Equillium, Inc.
Number of Employees (Ranges)
11 – 50
Email Address
info@equilliumbio.com0
Phone Number
+185824012000
Full Address
2223 Avenida De La Playa, Suite 105 La Jolla, California 92037, USA0
601 Gateway Blvd., Suite 1020 San Francisco, CA 94080 USA0
CIK Number
Place of Incorporation
Investors
IRS Number
821,554,7460
Total Funding Amount (USD)
50,000,000
Latest Funding Round Date
August 11, 2025
Stock Symbol
EQ0
Exchange
Board of Directors
CFO
Latest Funding Type
NAICS Code
325,4120
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
50,000,000
SIC Code
2,8340
Ticker Symbol
EQ
Equillium is a clinical-stage biopharmaceutical company developing immune-modifying therapies for severe immuno-inflammatory and autoimmune diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
